Girls like me definitely fall into the 20-side of the 80/20 Rule. In fact, I’d place myself — and all of you — into the top 2% of dog care consumers. Sometimes, however, this devotion gets interpreted as difficult.
I’d already planned and written last week’s 5-part series of posts on the adverse vaccine reaction financial settlement before Lilly suffered another setback, starting Friday, June 29. I’ve been posting updates on our Champion of My Heart Facebook Fan page, but here is a bigger recap.
Here is part five (of five) posts about my attempt to get financial help from the company that manufactured the rabies vaccine Lilly received January 23, 2012. Today, please take our dog blog poll. Would you have taken the money?
At long last, I give you part four (of five) posts that tell the story of our quest to get financial help from the company that manufactured the rabies vaccine Lilly received January 23, 2012. Following several days of being as factual, unemotional, and undramatic as possible – considering the circumstances – allow me, won’t you, to rant?
And, now, here is part three (of five) posts about my attempt to get financial help from the company that manufactured the rabies vaccine Lilly received January 23, 2012. Today, here are details on why I turned down the adverse vaccine reaction financial settlement.
This post is part two (of five) that address my quest to get financial help from the company that manufactured the rabies vaccine Lilly received January 23, 2012. Today’s post covers details on the two legal release clauses that gave me pause.
Here is part one (of five) posts that tell the story of our quest to get financial help from the company that manufactured the rabies vaccine Lilly received January 23, 2012. Today, we cover the timeline and process from my initial request to the official adverse vaccine reaction financial settlement offer.
Recently, we shared what (little) scientific research we could find about the incidence of severe neurological adverse vaccine reactions similar to Lilly’s. The short story is that is rare … really rare. At our appointment last Friday, I chatted with our veterinary neurologist about the data I found. He made a good point — the…
Lilly’s neurological deficits have grown significantly in the last 24 hours. I pretend we’re not headed back into life-threatening territory, but the worsening of Lilly’s elimination issues cause both worry and complication. I’m not sure I have the words to convey the heartbreak, so I won’t even try.
If you’d asked me last Thursday night about Lilly, I would have extolled her recovery virtues. Friday morning, however, Lilly suffered another major setback in her quest to heal from vaccine-induced meningoencephalomyelitis / meningoencephalitis (inflammation of the brain and lining of the brain and spinal cord).
